Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 7:23 pm Purchase | 2026-02-09 | 13G | SpyGlass Pharma, Inc. Common Stock SGP | Samsara BioCapital, L.P. | 2,109,953 6.300% | 2,109,953 (New Position) | Filing History |
| 2026-02-17 7:21 pm Purchase | 2026-02-09 | 13D | SpyGlass Pharma, Inc. Common Stock SGP | RA Capital Management, L.P. | 8,022,639 24.100% | 8,022,639 (New Position) | Filing History |
| 2026-02-13 6:21 pm Purchase | 2026-02-09 | 13D | SpyGlass Pharma, Inc. Common Stock SGP | New Enterprise Associates 17, L.P. | 7,393,823 22.200% | 7,393,823 (New Position) | Filing History |
| 2026-02-13 4:05 pm Purchase | 2026-02-09 | 13D | SpyGlass Pharma, Inc. Common Stock SGP | Gilde Healthcare Holding B.V. | 2,187,513 6.570% | 2,187,513 (New Position) | Filing History |
| 2026-02-13 11:36 am Purchase | 2026-02-06 | 13G | SpyGlass Pharma, Inc. Common Stock SGP | Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 2,500,012 7.800% | 2,500,012 (New Position) | Filing History |
| 2026-02-10 6:29 pm Purchase | 2026-02-09 | 13D | SpyGlass Pharma, Inc. Common Stock SGP | Vensana Capital I GP, LLC | 3,312,141 9.900% | 3,312,141 (New Position) | Filing History |